Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 371.82 million compared to CNY 216.41 million a year ago. Revenue was CNY 371.82 million compared to CNY 216.41 million a year ago.

Net income was CNY 15.7 million compared to CNY 39.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.0656 compared to CNY 0.1631 a year ago. Diluted earnings per share from continuing operations was CNY 0.0656 compared to CNY 0.1631 a year ago.